OHSU Team IDs Protein Signature Linked to 'BRCAness' Profile for Ovarian Cancer Recurrence
January 30, 2012
OHSU Team IDs Protein Signature Linked to 'BRCAness' Profile for Ovarian Cancer Recurrence
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Missed Opportunity: Would PGx Have Helped Sanofi-Aventis Avoid Phase III Failure for Iniparib?
February 2, 2011 / Pharmacogenomics Reporter - BG Medicine Q1 Revenues Fall but Galectin-3 Sales Jump as Company Pursues Expanded Use for Test
May 17, 2012 / ProteoMonitor - Biodesix Inks Deal to Test Veristrat in Phase III Clinical Trial for Kadmon Lung Cancer Drug
March 2, 2012 / ProteoMonitor - BG Medicine Says Data from 6,600-Patient Clinical Study Validates CardioScore Cardiac Risk Test
February 17, 2012 / ProteoMonitor - As BG Medicine Submits Cardio Risk Test to FDA, Some Pharmas See Opportunity for Preventive Therapy
January 11, 2012 / Pharmacogenomics Reporter